Insights / newsInsights
Insights / news

News Release

McGlinchey’s Daniel Shortt Instructs Cannabis Law at University of Washington School of Law

Read Time: 1 min

McGlinchey is pleased to announce that Daniel Shortt, an attorney in our Seattle office, was an Affiliate Instructor of Law at the University of Washington School of Law for the Spring 2024 semester. Alongside co-instructor Karen Boxx, Daniel taught the Cannabis Law Seminar. This seminar introduces students to the federal and state laws governing medical and recreational cannabis. Daniel took the inaugural class as a law student and has guest lectured every year since 2016.

Daniel is a regulatory and corporate attorney with experience in the hemp and marijuana industries. He advises federal agencies, top-tier cannabis corporations, and ambitious entrepreneurs on entering, succeeding in, and exiting the industry. Daniel provides highly tailored advice on heavily regulated topics, including contracts, regulatory guidance, administrative advice, employment issues, real estate transactions, mergers and acquisitions, and general legal counsel.

Frequently speaking on legal issues relating to cannabis across the country and abroad, Daniel is quoted on cannabis law in publications including Marijuana Moment, Hemp Industry Daily, The Washington Post, and Bloomberg, to name a few. As a founding member of the Washington State Bar Association’s cannabis law section and as a prolific writer on national and state-specific cannabis topics, Daniel has been instrumental in helping to shape the legal landscape of the industry.

Subscribe for Updates

Subscribe to receive emails from us regarding timely legal developments and events in your areas of interest.

sign up + subscribe >

Insights

News Release

McGlinchey Wins Top Law Firm at PBC Conference, Attorneys Named Global Top 200 Cannabis Lawyers

October 3, 2024

McGlinchey is pleased to announce its recognition as “Top Law Firm” by the PBC Conference 2024, a leading event that brings together the cannabis banking ecosystem with a focus on payments, banking, and compliance. This honor underscores the firm’s ability to integrate its deep experience in financial services with its growing leadership in the cannabis industry.

Cannabis Alert

Rescheduling Marijuana FAQs: How Do I Submit Comments on DEA’s Proposed Rules?

May 17, 2024

The Proposed Rule will be published on May 21, 2024. Once that occurs, the notice and comment period will open. Interested parties, including those currently involved in the cannabis industry as well as the many industries which cannabis rescheduling will affect, should start considering now whether they wish to submit a comment and request a hearing at which to speak and present a comment.

Cannabis Alert

What is the Timeline for Rescheduling Marijuana?

March 21, 2024

It is not yet known when the DEA will announce its recommendation or what the agency will recommend. Below, we explore the DEA’s options and potential timelines, as well as what will happen once the DEA does make a determination as to how marijuana will be scheduled going forward.

Alert

DEA is Going to Have a Hard Time Fighting Marijuana Rescheduling

January 16, 2024

The major importance of the HHS Letter is its impact on limiting the DEA’s next moves on marijuana. Although nothing is certain, it seems very likely that the DEA will move forward with the rulemaking process to reschedule marijuana.

Alert

Rescheduling Marijuana: Understanding the Legal Impacts

July 25, 2023

Marijuana is currently listed as a Schedule I substance in the Controlled Substances Act (CSA); this scheduling means the federal government concluded marijuana has no currently accepted medical use in any setting. In a prior post, we analyzed how the Department of Health and Human Services (HHS), along with the Department of Justice, can opt for descheduling or rescheduling marijuana under the CSA.